Free Trial

Ginkgo Bioworks (DNA) Expected to Announce Quarterly Earnings on Tuesday

Ginkgo Bioworks logo with Medical background

Ginkgo Bioworks (NYSE:DNA - Get Free Report) is anticipated to release its Q1 2025 earnings data after the market closes on Tuesday, May 6th. Analysts expect Ginkgo Bioworks to post earnings of ($1.23) per share and revenue of $38.70 million for the quarter.

Ginkgo Bioworks Stock Down 4.6 %

NYSE:DNA traded down $0.32 during mid-day trading on Tuesday, hitting $6.60. 404,980 shares of the stock traded hands, compared to its average volume of 1,471,635. Ginkgo Bioworks has a 12-month low of $5.00 and a 12-month high of $41.20. The company has a market cap of $383.02 million, a PE ratio of -0.50 and a beta of 1.29. The business's 50-day moving average price is $7.20 and its 200 day moving average price is $9.12.

About Ginkgo Bioworks

(Get Free Report)

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.

Featured Stories

Earnings History for Ginkgo Bioworks (NYSE:DNA)

Should You Invest $1,000 in Ginkgo Bioworks Right Now?

Before you consider Ginkgo Bioworks, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ginkgo Bioworks wasn't on the list.

While Ginkgo Bioworks currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines